---

Dolores Schendel

Chief Executive Officer, Medigene AG

Dolores has been a member of the German Research Foundation, German Cancer Aid and the European Research Council. She joined Medigene in 2014, when the company acquired Trianta Immunotherapy. She claims to be passionate about bringing individualized immunotherapies from bench to bed-side by moving herself and her team from in-depth research to the forefront of the biotech industry.

---

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016